Alternate Health (CSE: $AHG.C, OTC: $AHGIF)
Announces Completion of Initial Study to Treat #ZikaVirus Symptoms with
Hemp-Derived #Cannabinoids
TORONTO - May 16, 2017 (Investorideas.com Newswire) Alternate
Health Corp. (CSE:AHG, OTC:AHGIF), a diverse healthcare company revolutionizing
patient care and research through compliance and technology in the emerging
medical cannabis industry, announced today the completion of its initial study
to demonstrate the effectiveness of cannabinoids in treating chronic post-Zika
virus symptoms.
Read this news in full at http://www.investorideas.com/news/2017/marijuana/05161AHG.asp
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding
BC Residents and global Investors: Effective September 15 2008 - all BC
investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment